Peptide-laden vesicles light up in the presence of amyloid beta, providing an early diagnostic test (and possible treatment) for Alzheimer’s.
New blood test to diagnose Alzheimer’s disease via brain-derived protein
A sensitive blood test has been developed to detect a protein biomarker of Alzheimer’s disease known as brain-derived tau.
AI detects protein signatures for Alzheimer’s disease in the blood
A sensitive blood test for the early diagnosis of Alzheimer’s disease could be possible with nanoparticle arrays.
New blood test shows great promise in the diagnosis of Alzheimer’s disease
Researchers at Lund University hail potential game changer in early diagnosis.
Ultrasound therapy improves the memory of Alzheimer’s patients
In a small group of patients, language and memory showed improvement for up to 3 months after ultrasound brain stimulation therapy.
Potential New Biomarkers for Monitoring Alzheimer’s Disease
Scientists in Italy aim to keep Alzheimer’s disease in check.
Light-Triggered Dissociation of Alzheimer’s β-Amyloid Aggregates
Expanding beyond traditional photodynamic approach: photoelectrochemical oxidation of toxic Aβ aggregates with an inorganic photoelectrode.
Novel Formulation Additives for an Anti-Alzheimer’s Disease Drug
Tailor-made peptide-PEG conjugates are used as formulation additives to improve the water solubility of an anti-Alzheimer drug.
Amyloid beta: Bad for the brain, good for the liver
A new study finds that amyloid beta, a culprit in Alzheimer’s disease, is important for maintaining a healthy liver.
Are dietary supplement labels accurate?
A new study finds that prescription generic galantamine and the over-the-counter supplement are not created equal, despite label claims.